Features

Lawmakers across continents mull action to contain the rapid price hikes for existing and new drugs

Pfizer (NYSE: PFE) and Amgen (Nasdaq: AMGN) are rumoured to be considering a bid for Medivation just as French drug firm Sanofi (Euronext: SAN)...

With Pfizer and AstraZeneca hovering ominously, Sanofi faces stiff competition in its bid to acquire Medivation

Medicins Sans Frontieres takes a stand against Pfizer’s filing of an Indian patent on a highly effective pneumonia vaccine.

Corporate result announcements remained the key focus as well as the primary drivers for stock movements this week as the reporting season drew to...

With the earnings season in full swing this week investors focussed on the impact on stock moves as companies declared quarterly results....

Even though Opdivo arrived late to the party closely following Merck’s Keytruda, it has quickly captured the immuno-oncology drug market leaving...

Troubles don’t seem to go away for Canada-based Valeant Pharma (NYSE: VRX) with news of a probable sale doing the rounds now. The stock made a...

A recent exposé has highlighted how the quest for profits at the UK’s biggest pharmacy chain, Boots, is potentially putting the public at risk. So...

Early March, German drug major Merck and US pharma giant Pfizer (NYSE: PFE) agreed to develop a treatment for advanced ovarian cancer along with a...